Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The session is quick and well-tolerated
By avoiding the growth hormone receptor/IGF-1 pathway entirely, AOD-9604 eliminates the appetite-modulating effects that make growth hormone therapy challenging for weight management
While agonist peptides based on either scaffold are potent in rat obesity models 2,10,11,12,13 , only a transient weight loss effect is observed with sCT in mouse diet-induced obesity (DIO) models 14 , indicating that there may be distinctions in the mode of action of individual dual agonists
Any references to insulin-like growth factor, growth-related pathways, or metabolic endpoints are provided for scientific context only
A glimpse of the mechanisms related to renal fibrosis in diabetic nephropathy
A regulatory neighbor within the same tissue-response research area is KPV, a tripeptide that has likewise not received marketing authorization for any therapeutic use
US$ 29.60
US$ 27.53
US$ 26.96
US$ 21.84
US$ 24.61
